ASTH Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
972.5M
+0.8%
965.1M
+1.5%
950.5M
-0.6%
956.0M
+46.0%
654.8M
Cost of Revenue
868.5M
+1.1%
859.4M
+0.5%
855.5M
-0.4%
858.9M
+48.9%
576.8M
Gross Profit
104.0M
-1.6%
105.7M
+11.3%
95.0M
-2.2%
97.2M
+24.7%
78.0M
Operating Expenses
69.7M
-9.7%
77.2M
+0.7%
76.6M
-1.7%
78.0M
+35.3%
57.6M
R&D
0
0
0
0
0
SG&A
54.1M
-12.3%
61.7M
+2.5%
60.2M
-3.4%
62.4M
+23.0%
50.7M
Operating Income
34.3M
+20.3%
28.5M
+55.1%
18.4M
-4.2%
19.2M
-5.6%
20.3M
EBITDA
49.9M
+13.3%
44.0M
+26.5%
34.8M
-0.0%
34.8M
+27.8%
27.2M
Net Income
18.5M
+40.5%
13.1M
+100.1%
6.6M
+509.3%
1.1M
-89.5%
10.2M
EPS (Basic)
$0.40
+33.3%
$0.30
+150.0%
$0.12
+1100.0%
$0.01
-94.7%
$0.19
EPS (Diluted)
$0.40
+37.9%
$0.29
+141.7%
$0.12
+1100.0%
$0.01
-94.7%
$0.19
Shares (Diluted)
49.8M
+1.5%
49.1M
-1.3%
49.7M
+0.4%
49.5M
+0.0%
49.5M
Astrana Health (ASTH) โ€” Financials